Xiaowen Peng

This inventor holds 65 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Antiviral Agents (CPC class A61K). Top assignees: Enanta Pharmaceuticals, Inc., Novartis Ag. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaowen Peng. Retrieved from https://idiyas.com/inventor/xiaowen-peng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 65 (Patent Applications = 6)

% Patents Active = 63.1

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 3 (Patent Applications = 19)

Average Co-Inventor Count = 6.4

ph-index = 12

Forward Citations = 355(Granted Patents)

Forward Citations (Not Self Cited) = 203(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Auburndale, MA (US) (2012 - 2014)
Cambridge, MA (US) (2014 - 2017)
Sudbury, MA (US) (2017 - 2024)

Company Filing History:

65 out of 299

Enanta Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Antiviral Agents

Hepatitis B

Spiropyrrolidine

Macrocyclic Compounds

Benzimidazole Derivatives

Nucleoside Derivatives

Hepatitis C

Virus Inhibitors

Substituted Pyrrolo

Antiviral Compounds

Linked Dibenzimidazole

Pharmaceutical Innovations

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747248 - Processes for the preparation of substituted spirooxindole derivatives (2026-09-29),

2. 12643905 - Spiropyrrolidine derived antiviral agents (2026-06-02),

3. 12540141 - Spiropyrrolidine derived antiviral agents (2026-02-03),

4. 12496282 - Hepatitis B antiviral agents (2025-12-16),

5. 12479854 - Spiropyrrolidine derived antiviral agents (2025-11-25),

6. 12398147 - Macrocyclic spiropyrrolidine derived antiviral agents (2025-08-26),

7. 12054493 - Hepatitis B antiviral agents (2024-08-06),

8. 12011425 - Hepatitis B antiviral agents (2024-06-18),

9. 11976084 - Spiropyrrolidine derived antiviral agents (2024-05-07),

10. 11970502 - Macrocyclic antiviral agents (2024-04-30),

11. 11912714 - Spiropyrrolidine derived antiviral agents (2024-02-27),

12. 11760755 - Hepatitis B antiviral agents (2023-09-19),

13. 11596611 - Hepatitis B antiviral agents (2023-03-07),

14. 11472808 - Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents (2022-10-18),

15. 11339170 - Spiropyrrolidine derived antiviral agents (2022-05-24),

Title: The Innovative Journey of Xiaowen Peng

Introduction: Xiaowen Peng, a talented inventor based in Sudbury, MA (US), has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Xiaowen Peng holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a background in engineering and a passion for problem-solving, Xiaowen Peng has led numerous successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Xiaowen Peng has collaborated with top research institutions, leading companies, and brilliant minds in the field, fostering a culture of innovation and excellence.

Conclusion: Xiaowen Peng's dedication to pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and shape the future of various industries.

Profile summary based on public USPTO records.